Kindred Biosciences Stock Jumps On $440M Elanco Animal Buyout Deal
Elanco Animal Health Incorporated (NYSE:ELAN) has agreed to acquire Kindred Biosciences Inc (NASDAQ:KIN) for $9.25 per share, or approximately $440 million. The…
Elanco Announces Agreement To Acquire Kindred Biosciences For $9.25/Share
olt-on Acquisition Accelerates Elanco's Expansion in Pet Health
Elanco to host conference call for investment community at 8:00 am Eastern Time
Elanco will acquire all outstanding stock of
Last Week’s Notable Insider Buys: Activision, Avis Budget, Energy Transfer And More
Insider buying can be an encouraging signal for potential investors, especially when markets face uncertainty or are near all-time highs.
A couple of chief executive officers and an executive board chair were among the insiders buying shares this past week.
Earnings Scheduled For May 7, 2021
Companies Reporting Before The Bell
• Cronos Group (NASDAQ:CRON) is likely to report earnings for its first quarter.
Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge
Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions.
18 Drug Manufacturers—Specialty & Generic Stocks Moving In Wednesday’s Session
Gainers • Happiness Biotech, Inc. (NASDAQ:HAPP) shares surged 10.9% to $4.67 during Wednesday’s regular session. • Neos Therapeutics,…